HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bayer Aims For Global OTC Lead With Bolt-On Acquisition Plans

This article was originally published in The Tan Sheet

Executive Summary

Chairman Marijn Dekkers says the German company believes strong organic growth and consumer health pick-ups will help Bayer become the world leader in OTCs.


Related Content

Reckitt Deals Feed OTC Domination Plan
Sales & Earnings In Brief
Reckitt’s Schiff Buy Reflects Nutritional Industry “On Fire”
Bayer Migraine Formula Seeks Market Share Before Excedrin Returns
Charting The Course Of Product Liability: From Yasmin/Yaz To Actos


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts